We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+25.43%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.81B
AUM Growth
-$137M
Cap. Flow
-$1.22B
Cap. Flow %
-31.92%
Top 10 Hldgs %
21.26%
Holding
2,518
New
496
Increased
380
Reduced
669
Closed
943

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$36.2M
2
IMMU
Immunomedics Inc
IMMU
+$30.5M
3
ORCL icon
Oracle
ORCL
+$26.2M
4
LLY icon
Eli Lilly
LLY
+$26.2M
5
CVNA icon
Carvana
CVNA
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 8.87%
2 Consumer Discretionary 6.4%
3 Financials 4.85%
4 Industrials 4.41%
5 Healthcare 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USNA icon
1276
Usana Health Sciences
USNA
$419M
$238K 0.01%
3,095
-4,328
-58% -$335K
CENTA icon
1277
Central Garden & Pet Co Class A
CENTA
$2.42B
$237K 0.01%
8,141
-17,152
-68% -$502K
ING icon
1278
ING
ING
$100B
$237K 0.01%
25,093
-113,728
-82% -$976K
OIS icon
1279
Oil States International
OIS
$480M
$237K 0.01%
47,191
-128,923
-73% -$499K
SAIL
1280
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$237K 0.01%
+4,456
New +$209K
ECPG icon
1281
Encore Capital Group
ECPG
$2.08B
$235K 0.01%
+6,035
New +$219K
MYRG icon
1282
MYR Group
MYRG
$5.22B
$234K 0.01%
+3,887
New +$193K
POST icon
1283
Post Holdings
POST
$4.17B
$234K 0.01%
3,533
-20,386
-85% -$1.26M
SP
1284
DELISTED
SP Plus Corporation
SP
$234K 0.01%
+8,121
New +$199K
EVER icon
1285
EverQuote
EVER
$899M
$233K 0.01%
+6,248
New +$236K
TGNA
1286
DELISTED
TEGNA Inc
TGNA
$233K 0.01%
16,684
-53,069
-76% -$709K
LGF.A
1287
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$233K 0.01%
+20,508
New +$184K
RESI
1288
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$233K 0.01%
14,381
-198,877
-93% -$2.76M
CYRX icon
1289
CryoPort
CYRX
$762M
$232K 0.01%
+5,292
New +$252K
L icon
1290
Loews
L
$24B
$232K 0.01%
5,153
-75,670
-94% -$3.04M
OMF icon
1291
OneMain Financial
OMF
$7.42B
$232K 0.01%
+4,818
New +$190K
CXT icon
1292
Crane NXT
CXT
$3.03B
$231K 0.01%
8,568
-48,975
-85% -$1.08M
GKOS icon
1293
Glaukos
GKOS
$10.2B
$231K 0.01%
+3,066
New +$194K
HLI icon
1294
Houlihan Lokey
HLI
$8.54B
$231K 0.01%
+3,432
New +$222K
PHR icon
1295
Phreesia
PHR
$682M
$231K 0.01%
+4,263
New +$183K
TECK icon
1296
Teck Resources
TECK
$29.3B
$231K 0.01%
+12,723
New +$196K
OM icon
1297
Outset Medical
OM
$87.5M
$230K 0.01%
+270
New +$208K
AKTS
1298
DELISTED
Akoustis Technologies Inc
AKTS
$230K 0.01%
+18,824
New +$165K
C icon
1299
Citigroup
C
$222B
$228K 0.01%
3,700
-333,738
-99% -$17M
PLCE icon
1300
Children's Place
PLCE
$55.6M
$228K 0.01%
+4,550
New +$166K

Similar funds

Paloma Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Paloma Partners held 2,518 positions worth $3.81B, down 3.5% from $3.95B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Paloma Partners withdrew a net $1.22B in Q4 2020, closing 943 positions and reducing 669 holdings. Its most notable exit was Immunomedics Inc, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Paloma Partners opened a new position in Danaher worth $13.7M.

  • Paloma Partners's largest Q4 2020 buy was Danaher: 69,494 shares worth $13.7M.
  • Paloma Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $56.5M increase.
  • Paloma Partners's biggest Q4 2020 reduction was Block Inc, cutting an estimated $36.2M.
  • Paloma Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $30.5M.
  • Paloma Partners's ten largest holdings make up 21% of its $3.81B portfolio in Q4 2020.
  • Paloma Partners opened 496 new positions and closed 943 in Q4 2020.
  • Paloma Partners's portfolio value fell 3.5% quarter-over-quarter to $3.81B.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.